Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.http://t.co/Rn9yb0G3XA
Big evidence gaps on sulphonylurea monotherapy for type 2 #diabetes, including patient important outcomes http://t.co/TXXz48xtQt #Cochrane
Big evidence gaps on sulphonylurea monotherapy for type 2 #diabetes, including patient important outcomes http://t.co/TXXz48xtQt #Cochrane
Big evidence gaps on sulphonylurea monotherapy for type 2 #diabetes, including patient important outcomes http://t.co/TXXz48xtQt #Cochrane
Big evidence gaps on sulphonylurea monotherapy for type 2 #diabetes, including patient important outcomes http://t.co/TXXz48xtQt #Cochrane
No hay suficientes pruebas para el uso en monoterapia de SU en DM2 http://t.co/dhhUipcqTK
No hay suficientes pruebas para el uso en monoterapia de SU en DM2 http://t.co/dhhUipcqTK
Authors' conclusions There is insufficient evidence from RCTs to support the decision as to whether to... http://t.co/XYFTlvqcq7